|3Oct 22, 8:30 PM ET

KNIGHT THERAPEUTICS INTERNATIONAL SA 3

3 · Synergy CHC Corp. · Filed Oct 22, 2024

Insider Transaction Report

Form 3
Period: 2024-10-22
Holdings
  • Common Stock, par value $0.00001 per share

    (indirect: Held through Knight Therapeutics International SA, a subsidiary of Knight Therapeutics Inc.)
    1,482,844

Documents

1 file
  • 3
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT